1. Home
  2. DEC vs ABCL Comparison

DEC vs ABCL Comparison

Compare DEC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diversified Energy Company plc

DEC

Diversified Energy Company plc

HOLD

Current Price

$13.20

Market Cap

1.3B

Sector

N/A

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DEC
ABCL
Founded
2001
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
DEC
ABCL
Price
$13.20
$3.11
Analyst Decision
Strong Buy
Buy
Analyst Count
6
5
Target Price
$21.40
$7.75
AVG Volume (30 Days)
538.4K
4.6M
Earning Date
02-26-2026
02-24-2026
Dividend Yield
8.78%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,148,432,000.00
$35,325,000.00
Revenue This Year
$126.94
$25.45
Revenue Next Year
N/A
$10.07
P/E Ratio
N/A
N/A
Revenue Growth
64.19
7.17
52 Week Low
$10.08
$1.89
52 Week High
$17.03
$6.52

Technical Indicators

Market Signals
Indicator
DEC
ABCL
Relative Strength Index (RSI) 49.68 40.09
Support Level $12.80 $2.93
Resistance Level $13.59 $3.28
Average True Range (ATR) 0.41 0.23
MACD 0.07 -0.07
Stochastic Oscillator 71.36 26.30

Price Performance

Historical Comparison
DEC
ABCL

About DEC Diversified Energy Company plc

Diversified Energy Co is an independent energy company focused on natural gas and liquids production, transportation, marketing and well retirement, located within the Appalachian and Central regions of the United States. Its principal focus is on enhancing producing wells, not drilling new wells, thereby allowing it to optimise PDP revenues and reduce costs. The company derives revenues from the sale of oil, natural gas and natural gas liquids.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: